| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 9,737,679 | 2,514,150 |
| Net cash provided by (used in) investing activities | - | 0 |
| Net increase (decrease) in cash | 4,050,979 | -1,317,381 |
| Cash and cash equivalents at beginning of period | 3,559,361 | - |
| Cash and cash equivalents at end of period | 7,610,340 | - |
Tharimmune, Inc. (THAR)
Tharimmune, Inc. (THAR)